Genomics

Dataset Information

0

Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR/Cas9 system


ABSTRACT: Exonic duplications account for 10-15% of all mutations in Duchenne muscular dystrophy (DMD), a severe hereditary neuromuscular disorder. We report a novel CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat)/Cas9-based strategy to correct the most frequent (exon 2) duplication in the DMD gene by targeted deletion, and tested the efficacy of such an approach in patient-derived myogenic cells. We demonstrate restoration of wild-type dystrophin expression at transcriptional and protein level in myotubes derived from genome-edited myoblasts in the absence of selection. Removal of the duplicated exon was achieved by the use of only one gRNA directed against an intronic duplicated region, thereby increasing editing efficiency and reducing the risk of off-target effects. This study opens a novel therapeutic perspective for patients carrying disease-causing duplications independently from the duplication extension.

ORGANISM(S): Homo sapiens

PROVIDER: GSE83658 | GEO | 2017/06/23

SECONDARY ACCESSION(S): PRJNA326658

REPOSITORIES: GEO

Similar Datasets

2024-01-01 | GSE248257 | GEO
2023-07-11 | PXD039533 | Pride
| E-GEOD-44096 | biostudies-arrayexpress
2018-03-01 | GSE66571 | GEO
2013-08-06 | GSE44096 | GEO
2023-07-20 | GSE235673 | GEO
2023-09-30 | GSE237014 | GEO
2020-08-19 | PXD020566 | Pride
2022-01-29 | GSE195480 | GEO
2007-10-01 | GSE8090 | GEO